Skip to Content

CNN – Health

After the US Food and Drug Administration granted full approval to Pfizer's shot in August

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more

By Elizabeth Cohen, CNN Senior Medical Correspondent Despite hopes that full approval of Pfizer’s Covid-19 vaccine would convince large numbers of vaccine-hesitant Americans to roll up their sleeves, a federal government analysis provided to CNN suggests approval was not a silver bullet. After the US Food and Drug Administration granted full approval to Pfizer’s shot

Continue Reading
After the US Food and Drug Administration granted full approval to Pfizer's shot in August

Full FDA approval of Pfizer’s Covid-19 vaccine had only a modest impact on uptake. Here’s what mattered more

By Elizabeth Cohen, CNN Senior Medical Correspondent Despite hopes that full approval of Pfizer’s Covid-19 vaccine would convince large numbers of vaccine-hesitant Americans to roll up their sleeves, a federal government analysis provided to CNN suggests approval was not a silver bullet. After the US Food and Drug Administration granted full approval to Pfizer’s shot

Continue Reading
The US is averaging around 107

Covid-19 numbers are improving. Don’t let history repeat itself with yet another resurgence, doctors say

By Holly Yan and Susannah Cullinane, CNN As Covid-19 numbers gradually improve, health experts have an urgent message: Don’t get cocky and relax. “We can’t get overconfident. Every time we do and we put our guard down … we get another surge with another variant,” said Dr. Jorge Rodriguez, a viral researcher and internal medicine

Continue Reading
A health care worker administers a dose of the Pfizer-BioNTech Covid-19 vaccine during a vaccination event in Birmingham

‘Every one of those deaths is unnecessary,’ expert says of rising Covid-19 US death toll as tens of millions remain unvaccinated

By Travis Caldwell, CNN With a first-of-its-kind antiviral pill against Covid-19 potentially headed towards distribution, the health care community may soon have another tool to combat a virus that has claimed the lives of more than 700,000 Americans. Merck and Ridgeback Biotherapeutics created an antiviral pill the companies say can reduce risk of Covid-19 hospitalization

Continue Reading
Merck & Co. said Oct. 1 that its experimental Covid-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus.

Covid-19 antiviral pill could be a game changer, but vaccines are still America’s way out of the pandemic, experts say

By Aya Elamroussi, CNN A pill that could potentially treat Covid-19 is a “game-changer,” but experts are emphasizing that it’s not an alternative to vaccinations — which remain the most effective path to ending the coronavirus pandemic if enough people get their shots. Roughly 255,767 people are becoming fully vaccinated in the US each day,

Continue Reading
A pill has cut the risk of hospitalization or death from Covid-19 by half in a study

Covid-19 antiviral pill could be a game changer, but vaccines are still America’s way out of the pandemic, experts say

By Aya Elamroussi, CNN A pill that could potentially treat Covid-19 is a “game-changer,” but experts are emphasizing that it’s not an alternative to vaccinations — which remain the most effective path to ending the coronavirus pandemic if enough people get their shots. Roughly 255,767 people are becoming fully vaccinated in the US each day,

Continue Reading
A pill has cut the risk of hospitalization or death from Covid-19 by half in a study

US surpasses 700,000 Covid-19 deaths

By Travis Caldwell and Naomi Thomas, CNN The US surpassed 700,000 deaths from Covid-19 on Friday, 108 days after the country reached 600,000 deaths from the virus, according to data from Johns Hopkins University. The grim figure comes after another violent round of surging of infections, hospitalizations and deaths fueled by the highly transmissible Delta

Continue Reading
The study did find a small percentage of people were able to successfully stop their antidepressant without having another depressive episode.

Stopping antidepressants may lead to relapse, study finds. Here’s what you can do

By Sandee LaMotte, CNN Over half of people with chronic depression who attempted to stop their antidepressant medication relapsed into depression by the end of a year, compared to those who did not stop medicating, according to a randomized, double-blinded clinical trial released Wednesday. The research, published in the New England Journal of Medicine, found

Continue Reading